Clinical correlation of chromosome 22q11.2 fluorescent in situ hybridization analysis and velocardiofacial syndrome

Cleft Palate-Craniofacial Journal

Volumn 44, Issue 1, 2007, Pages 62-66

  Oh, Albert K ^a,d   Workman, Laura A ^b   Wong, Granger B ^c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Sutter Medical Center   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Hunnewell 178 ^*  (United States)

Author keywords

22q11.2 microdeletion; FISH analysis; Velocardiofacial syndrome

Indexed keywords

ADOLESCENT; ADULT; CHILD; CHROMOSOME 22Q; CLEFT LIP; CLEFT PALATE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL FEATURE; CORRELATION ANALYSIS; CRANIOFACIAL MALFORMATION; DEVELOPMENTAL DISORDER; FACIES; FAMILY HISTORY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; HEART DISEASE; HUMAN; INFANT; KIDNEY MALFORMATION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTIPLE REGRESSION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SHORT STATURE; STATISTICAL ANALYSIS; VELOCARDIOFACIAL SYNDROME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 22; CLEFT PALATE; DEVELOPMENTAL DISABILITIES; DIGEORGE SYNDROME; DWARFISM; FACIES; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; KIDNEY; MALE; MENTAL DISORDERS; RETROSPECTIVE STUDIES; VELOPHARYNGEAL INSUFFICIENCY;

EID: 33846221511     PISSN: 10556656     EISSN: None     Source Type: Journal    
DOI: 10.1597/05-192     Document Type: Review

References (36)

1. Adeyinka A, Stockera KJ, Flynn HC, Lorentz CP, Ketterling RP, Jalal SM. Familial 22q11.2 deletions in DiGeorge/velocardiofacial syndrome are predominantly smaller than the commonly observed 3mb. Genet Med. 2004;6: 517-520.
2. Bartsch O, Nemeckova M, Kocarek E, Wagner A, Puchmajerova A, Poppe M, Ounap K, Goetz P. DiGeorge/velocardiofacial syndrome: FISH studies on chromosomes 22q11 and 10p14, and clinical reports on the proximal 22q11 deletion. Am J Med Genet. 2003;117:1-5.
3. Bassett AS, Hodgkinson K, Chow EWC, Correia S, Scutt LE, Weksberg R. 22q11 deletion syndrome in adults with schizophrenia. Am J Med Genet (Neuropsychiatr Genet). 1998;81:328-337.
4. Carlson C, Sirotkin H, Pandita R, Goldberg R, McKie J, Wadey R, Patanjali SR, Weissman SM, Anyane-Yeboa K, Warburton D, Scambler P, Shprintzen R, Kucherlapati R, Morrow BE. Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients. Am J Hum Genet. 1997;61:620-629.
5. Cuneo BF. 22q11.2 deletion syndrome: DiGeorge, velocardiofacial, and conotruncal anomaly face syndromes. Curr Opin Pediatr. 2001;13:465-472.
6. D'Antonio LL, Davio M, Koller K, Punjabi A, Hardesty RA. Results of Furlow z-plasty in patients with velocardiofacial syndrome. Plast Reconstr Surg. 2001;107:1077-1079.
7. Daw S, Taylor C, Kraman M, Call K, Mao J, Schuffenhauer S, Meitinger T, Lipson T, Goodship J, Scambler P. A common region of 10p deleted in DiGeorge and velocardiofacial syndromes. Nat Genet. 1996;13:458-460.
8. Demczuk S, Aurias A. DiGeorge syndrome and related syndromes associated with 22q11.2 deletions: a review. Ann Genet. 1995;38:59-76.
9. Devriendt K, Fryns JP, Mortier G, van Thienen MN, Keymole K. The annual incidence of DiGeorge/velocardiofacial syndrome. J Med Genet. 1998;35: 789-790.
10. Driscoll DA, Salvin J, Sellinger B, Budarf ML, McDonald-McGinn DM, Zackai EH, Emanuel BS. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counseling and prenatal diagnosis. J Med Genet. 1993;30:813-817.
11. Driscoll DA, Spinner NB, Budarf ML, McDonald-McGinn DM, Zackai EH, Goldberg RB, Shprintzen RJ, Saal HM, Zonana J, Jones MC, Mascarello JT, Emanuel BS. Deletions and microdeletions of 22q11.2 in velo-cardiofacial syndrome. Am J Med Genet. 1992;44:261-268.
12. Fernandez L, Lapunzina P, Arjona D, Lopez Pajares I, Garcia-Guereta L, Elorza D, Burgueros M, De Torres ML, Mori MA, Palomares M, Garcia-Alix A, Delicado A. Comparative study of three diagnostic approaches (FISH, STRs and MLPA) in 30 patients with 22q11.2 deletion syndrome. Clin Genet. 2005;68:373-378.
13. Goldberg RB, Motzkin B, Marion RW, Scambler PJ, Shprintzen RJ. Velo-cardio-facial syndrome: a review of 120 patients. Am J Med Genet. 1993;45: 313-319.
14. Greenberg F, Elder FFB, Haffner P, Northrup H, Ledbetter D. Cytogenetic findings in a prospective series of patients with DiGeorge anomaly. Am J Hum Genet. 1988;434:605-611.
15. Hultman CS, Riski JE, Cohen ST, Burstei, FD, Boydston WR, Hudgins RJ, Grattan-Smith D, Uhas K, Simms C. Chiari malformation, cervical spine anomalies, and neurologic deficits in velocardiofacial syndrome. Plast Reconstr Surg. 2000;106:16-24.
16. Jones KL. Smith's Recognizable Patterns of Human Malformation. 5th ed. Philadelphia: WB Saunders; 1997:266-267.
17. Kitsiou-Tzeli S, Kolialexi A, Fryssira H, Galla-Voumvouraki A, Salavoura K, Kanariou M, Tsangaris GT, Kanavakis E, Mavrou A. Detection of 22q11.2 deletion among 139 patients with DiGeorge/velocardiofacial syndrome features. In Vivo. 2004;18:603-608.
18. Lai JP, Lo LJ, Won HF, Wang SR, Yun C. Vascular abnormalities in the head and neck area in velocardiofacial syndrome. Chang Gung Med J. 2004;27: 586-593.
19. Lipson AH, Yuille D, Angel M, Thompson PG, Vandervoord JG, Beckenham EJ. Velocardiofacial (Shprintzen) syndrome: an important syndrome for the dysmorphologist to recognize. J Med Genet. 1991;28:596-604.
20. Losken A, William JK, Burstein FD, Malick D, Riski JE. An outcome evaluation of sphincter pharyngoplasty for the management of velopharyngeal insufficiency. Plast Reconstr Surg. 2003;112:1755-1761.
21. MacKenzie-Stepner K, Witzel MA, Stringer DA, Lindsay WK, Munro IR, Hughes H. Abnormal carotid arteries in the velocardiofacial syndrome: a report of three cases. Plast Reconstr Surg. 1987;80:347-351.
22. Maynard TM, Haskell GT, Lieberman JA, LaMantia AS. 22q11 ds: genomic mechanisms and gene function in DiGeorge/velocardiofacial syndrome. Int J Dev Neurosci. 2002;20:407-419.
23. Mehendale FV, Birch MJ, Birrkett L, Sell D, Sommerlad BC. Surgical management of velopharyngeal incompetence in velocardiofacial syndrome. Cleft Palate Craniofac J. 2004;41:124-135.
24. Mehendale FV, Sommerlad BC. Surgical significance of abnormal internal carotid arteries in velocardiofacial syndrome in 43 consecutive hynes pharyngoplasties. Cleft Palate Craniofac J. 2004;41:368-374.
25. Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry. 1999;56:940-945.
26. Perez E, Sullivan KE. Chromosome 22q11.2 deletion syndrome (DiGeorge and velocardiofacial syndromes). Curr Opin Pediatr. 2002;14:678-683.
27. Reish O, Finkelstein Y, Mesterman R, Nachmani A, Wolach B, Fejgin M, Amiel A. Is isolated palatal anomaly an indication to screen for 22q11 region deletion? Cleft Palate Craniofac J. 2003;40:176-179.
28. Ross DA, Witzel MA, Armstrong DC, Thomson HG. Is pharyngoplasty a risk in velocardiofacial syndrome? An assessment of medially displaced carotid arteries. Plast Reconstr Surg. 1996;98:1182-1190.
29. Ryan AK, Goodship JA, Wilson DI, Philip N, Levy A, Seidel H, Schuffenhauer S, Oechsler H, Belohradsky B, Prieur M, Aurias A, Raymond FL, Clayton-Smith J, Hatchwell E, McKeown C, Beemer FA, Dallapiccola B, Novelli G, Hurst JA, Ignatius J, Green AJ, Winter RM, Brueton L, Brondum-Nielsen K, Scambler PJ, et al. Spectrum of clinical features associated with interstitital chromosome 22q11 deletions: a European collaborative study. J Med Genet. 1997;34:798-804.
30. Shouman N, Pabst B, Arslan-Kirchner M, Eckardt A, Schonweiler R, Ptok M, Mehraein Y, Schmidtke J, Miller K. Search for deletion 22q11.2 in interphase nuclei of buccal mucosa of patients ascertained by isolated cleft palate: a new diagnostic approach. Int J Oral Maxillofac Surg. 2003;32:198-200.
31. Shprintzen RJ. Velo-cardio-facial syndrome: specialist fact sheet, 1998. Available at http://www.vcfsef.org/articles/en/pdf/factsheet.pdf. Accessed July 5, 2006.
32. Shprintzen RJ, Goldberg RB, Lewin ML, Sidoti EJ, Berkman MD, Argamaso RV, Young D. A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome. Cleft Palate J. 1978;15:56-62.
33. Shprintzen RJ, Siegel-Sadewitz VL, Amato J, Goldberg RB. Retrospective diagnoses of previously missed syndromic disorders among 1000 patients with cleft lip, cleft palate, or both. Birth Defects Orig Artic Ser. 1985;21: 85-92.
34. Simon TJ, Bish JP, Bearden CE, Ding L, Ferrante S, Nguyen V, Gee JC, McDonald-McGinn DM, Zackai EH, Emanuel BS. A multilevel analysis of cognitive dysfunction and psychopathology associated with chromosome 22qll.2 deletion syndrome in children. Dev Psychopathol. 2005;17:753-784.
35. Swillen A, Devriendt K, Legius E, Prinzie P, Vogels A, Ghesquiere P, Fryns JP. The behavioral phenotype in velo-cardio-facial syndrome (VCFS): from infancy to adolescence. Genet Couns. 1999;10:79-88.
36. Witt PD, Miller DC, Marsh JL, Muntz HR, Grames LM. Limited value of preoperative cervical vascular imaging in patients with velocardiofacial syndrome. Plast Reconstr Surg. 1998;101:1184-1195.